Oxford BioMedica PLC (OXB) — Net Asset Quality Index

Latest as of June 2025: 15.1%

Oxford BioMedica PLC (OXB) has a Net Asset Quality Index of 15.1% as of June 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of GBX216.32 Million minus total liabilities of GBX183.59 Million yields net assets of GBX32.73 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check Oxford BioMedica PLC liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Quality Index

15.1%
Equity / Total Assets

Net Assets

GBX32.73 Million
GBX

Total Assets

GBX216.32 Million
GBX

Total Liabilities

GBX183.59 Million
GBX

Oxford BioMedica PLC Net Asset Quality Index Over Time (1996–2024)

This chart shows how Oxford BioMedica PLC's Net Asset Quality Index has evolved across 30 annual periods from 1996 to 2024. As of June 2025, the index stands at 15.1%, representing net assets of GBX32.73 Million against total assets of GBX216.32 Million GBX. See Oxford BioMedica PLC current assets vs equity to evaluate short-term liquidity relative to the company's equity base.

Annual Net Asset Quality Index for Oxford BioMedica PLC (1996–2024)

The table below presents the year-by-year Net Asset Quality Index for Oxford BioMedica PLC from 1996 to 2024, covering 30 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see OXB stock market capitalisation.

Year Quality Index Net Assets (GBX) Total Assets Total Liabilities Change (pp)
2024 26.1% GBX60.49 Million GBX231.64 Million GBX171.16 Million ▼ -4.7 pp
2023 30.8% GBX77.83 Million GBX252.34 Million GBX174.51 Million ▼ -20.5 pp
2022 51.3% GBX236.19 Million GBX460.18 Million GBX223.99 Million ▼ -27.6 pp
2021 79.0% GBX187.34 Million GBX237.23 Million GBX49.89 Million ▲ +17.7 pp
2020 61.3% GBX112.75 Million GBX183.93 Million GBX71.18 Million ▼ -0.2 pp
2019 61.5% GBX75.63 Million GBX122.93 Million GBX47.30 Million ▲ +30.6 pp
2018 30.9% GBX34.74 Million GBX112.40 Million GBX77.66 Million ▲ +21.5 pp
2017 9.4% GBX6.15 Million GBX65.40 Million GBX59.26 Million ▼ -12.8 pp
2016 22.2% GBX12.62 Million GBX56.94 Million GBX44.33 Million ▲ +1.1 pp
2015 21.0% GBX10.89 Million GBX51.85 Million GBX40.96 Million ▼ -47.1 pp
2014 68.2% GBX23.04 Million GBX33.80 Million GBX10.77 Million ▲ +2.9 pp
2013 65.2% GBX8.90 Million GBX13.64 Million GBX4.75 Million ▼ -15.2 pp
2012 80.4% GBX19.64 Million GBX24.42 Million GBX4.78 Million ▲ +12.3 pp
2011 68.1% GBX17.77 Million GBX26.09 Million GBX8.32 Million ▲ +22.8 pp
2010 45.3% GBX11.61 Million GBX25.64 Million GBX14.04 Million ▼ -2.5 pp
2009 47.7% GBX20.98 Million GBX43.95 Million GBX22.97 Million ▼ -6.2 pp
2008 54.0% GBX23.27 Million GBX43.12 Million GBX19.85 Million ▲ +1.8 pp
2007 52.2% GBX31.93 Million GBX61.16 Million GBX29.23 Million ▼ -32.5 pp
2006 84.7% GBX30.09 Million GBX35.54 Million GBX5.45 Million ▼ -10.0 pp
2005 94.6% GBX46.60 Million GBX49.24 Million GBX2.64 Million ▲ +2.4 pp
2004 92.3% GBX26.38 Million GBX28.58 Million GBX2.21 Million ▼ -3.6 pp
2003 95.9% GBX35.21 Million GBX36.71 Million GBX1.50 Million ▲ +0.6 pp
2002 95.3% GBX25.53 Million GBX26.79 Million GBX1.26 Million ▼ -0.2 pp
2001 95.5% GBX37.51 Million GBX39.26 Million GBX1.76 Million ▲ +4.9 pp
2000 90.6% GBX12.98 Million GBX14.32 Million GBX1.34 Million ▲ +8.0 pp
1999 82.6% GBX3.80 Million GBX4.60 Million GBX801.00K ▼ -8.2 pp
1998 90.8% GBX4.76 Million GBX5.24 Million GBX480.00K ▲ +4.6 pp
1997 86.2% GBX2.76 Million GBX3.20 Million GBX441.00K ▼ -3.7 pp
1996 89.9% GBX1.12 Million GBX1.25 Million GBX126.00K ▲ +0.0 pp
1996 89.9% GBX1.12 Million GBX1.25 Million GBX126.00K —
pp = percentage points